Primary predictors of survival outcomes for HER2-positive advanced breast cancer patients initiating ado-trastuzumab emtansine.
Sign Up to like & getrecommendations! Published in 2019 at "Breast"
DOI: 10.1016/j.breast.2019.05.011
Abstract: OBJECTIVES Common therapies for HER2-positive advanced breast cancer (ABC) are associated with heterogeneity in prognosis and treatment benefit. Prognostic models of survival outcomes with ado-trastuzumab-emtansine (T-DM1) have not been evaluated. MATERIAL AND METHODS A pre-treatment… read more here.
Keywords: prognostic groups; treatment; her2 positive; patients initiating ... See more keywords
Surgery for metastases of renal cell carcinoma: outcome of treatments and preliminary assessment of Leuven-Udine prognostic groups in the targeted therapy era
Sign Up to like & getrecommendations! Published in 2018 at "Scandinavian Journal of Urology"
DOI: 10.1080/21681805.2018.1553893
Abstract: Abstract Aim: This study was conducted to evaluate the efficacy of surgical treatment for metastases accompanied by modern targeted therapies and to evaluate the performance of the Leuven-Udine (L.U.) prognostic groups model. Methods: This retrospective… read more here.
Keywords: renal cell; cell carcinoma; udine prognostic; leuven udine ... See more keywords
Real-world prognostic model for malignant pleural mesothelioma.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.15_suppl.e20562
Abstract: e20562 Background: Two mesothelioma prognostic models have been suggested: European Organisation for Research and Treatment of Cancer (EORTC) and Cancer and Leukaemia Group B (CALGB) models. Both were based on clinical trial patients enrolled in… read more here.
Keywords: pleural mesothelioma; prognostic groups; histology; malignant pleural ... See more keywords